Clinical Trial Update: Cabozantinib and Atezolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer, The AtezoCab Trial [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating the combination of cabozantinib and atezolizumab for metastatic castration-resistant prostate cancer is currently recruitin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer
• Prostate Cancer

Drugs mentioned

• Atezolizumab (atezolizumab)
• cabozantinib (cabozantinib)

Snippet

Sponsor: University of Utah | Conditions: Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma | Phase 2 | Status: RECRUITING